Caldarelli, M.; Brisinda, D.; De Matteis, G.; De Vito, F.; Gambini, G.; Cianci, R.; Gambassi, G.
Immune Checkpoint Inhibitor-Induced Ocular Toxicity: A Case of Pembrolizumab-Associated Corneal Ulceration and Evisceration. Reports 2025, 8, 154.
https://doi.org/10.3390/reports8030154
AMA Style
Caldarelli M, Brisinda D, De Matteis G, De Vito F, Gambini G, Cianci R, Gambassi G.
Immune Checkpoint Inhibitor-Induced Ocular Toxicity: A Case of Pembrolizumab-Associated Corneal Ulceration and Evisceration. Reports. 2025; 8(3):154.
https://doi.org/10.3390/reports8030154
Chicago/Turabian Style
Caldarelli, Mario, Donatella Brisinda, Giuseppe De Matteis, Francesco De Vito, Gloria Gambini, Rossella Cianci, and Giovanni Gambassi.
2025. "Immune Checkpoint Inhibitor-Induced Ocular Toxicity: A Case of Pembrolizumab-Associated Corneal Ulceration and Evisceration" Reports 8, no. 3: 154.
https://doi.org/10.3390/reports8030154
APA Style
Caldarelli, M., Brisinda, D., De Matteis, G., De Vito, F., Gambini, G., Cianci, R., & Gambassi, G.
(2025). Immune Checkpoint Inhibitor-Induced Ocular Toxicity: A Case of Pembrolizumab-Associated Corneal Ulceration and Evisceration. Reports, 8(3), 154.
https://doi.org/10.3390/reports8030154
